Author:
Lopes Barreto Deirisa,Struijk Dirk G.
Reference33 articles.
1. Atkinson AJ, Colburn WA, DeGruttola VG, et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Therm. 2001;69:89–95.
2. Atzler D, Schwedhelm E, Zeller T. Integrated genomics and metabolomics in nephrology. Nephrol Dial Transplant. 2014;29:1467–74.
3. Bonomini M, Sirolli V, Magni F, et al. Proteomics and nephrology. J Nephrol. 2012;25:865–71.
4. Brewis IA, Topley N. Proteomics and peritoneal dialysis: early days but clear potential. Nephrol Dial Transplant. 2010;25:1749–53.
5. Coester AM, Smit W, Struijk DG, et al. Peritoneal functions in clinical practice: the importance of follow-up and its measurement in patients. Recommendations for patient information and measurement of peritoneal function. NDT Plus. 2009;2:104–10.